The GTT and ITT data in the present study revealed that STM treatment significantly promoted obesity-associated glucose tolerance and insulin sensitivity, although overnight fasting may not be optimal in our GTT test and a short time (4‒6 h) fasting may be more appropriate[37]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.